Biotechnology
Austrian companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Lakefront Biotherapeutics ranks as the top gainer, and Valneva SE sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGNAmgen Inc. | 230.4 B EUR | 413.60 EUR | −0.86% | 0 | 0.00 | 27.18 | 15.22 EUR | +38.07% | 2.08% | Health technology | Neutral |
 GILDGilead Sciences, Inc. | 192.75 B EUR | 150.26 EUR | −1.83% | 25 | 0.28 | — | −2.78 EUR | −150.52% | 1.86% | Health technology | Buy |
 MRNAModerna, Inc. | 91.88 B EUR | 234.25 EUR | +6.65% | 133 | 0.69 | — | −6.99 EUR | −9.55% | 0.00% | Health technology | Neutral |
 ARGXargenx SE | 51.25 B EUR | 796.2 EUR | −3.72% | 0 | 0.00 | 35.36 | 22.51 EUR | +24.40% | 0.00% | Health technology | Strong buy |
 LONNLonza Group AG | 49.13 B EUR | 715.6 EUR | −2.00% | 0 | 0.00 | — | −1.68 EUR | −115.37% | 0.76% | Health technology | Buy |
 IQVHIQVIA Holdings Inc | 38.72 B EUR | 241.9 EUR | +2.28% | 0 | 0.00 | 33.30 | 7.26 EUR | +17.03% | 0.00% | Health technology | Strong buy |
 GMABGenmab A/S | 28.53 B EUR | 472.9 EUR | −2.27% | 0 | 0.00 | 43.71 | 10.82 EUR | −40.96% | 0.00% | Health technology | Buy |
 BMRNBioMarin Pharmaceutical Inc. | 9.86 B EUR | 49.98 EUR | −1.50% | 4 | 0.01 | — | −0.09 EUR | −104.02% | 0.00% | Health technology | Buy |
 BAVABavarian Nordic A/S | 2.61 B EUR | 32.50 EUR | −1.28% | 1 | — | 12.18 | 2.67 EUR | +9.77% | 0.00% | Health technology | Strong buy |
 ZEALZealand Pharma A/S | 2.1 B EUR | 31.20 EUR | −1.61% | 0 | 0.00 | 6.05 | 5.16 EUR | −58.53% | 0.00% | Health technology | Buy |
 LKFTLakefront Biotherapeutics | 1.96 B EUR | 29.08 EUR | −4.22% | 0 | — | 3.21 | 9.05 EUR | — | 0.00% | Health technology | Buy |
 NVAXNovavax, Inc. | 1.56 B EUR | 9.50 EUR | +2.26% | 5 | 0.02 | — | −1.33 EUR | −169.59% | 0.00% | Health technology | Buy |
 VLAValneva SE | 481.73 M EUR | 2.467 EUR | −4.19% | 538 | 0.74 | — | −0.90 EUR | −117.39% | 0.00% | Health technology | Strong buy |